HANSA BIOPHARMA AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 29.06 SEK | -1.42% |
|
-2.61% | +10.92% |
| 07:00am | Hansa Biopharma AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Apr. 12 | Hansa Biopharma Approves SEK372 Million Directed Share Issue | MT |
Evolution of the average Target Price on Hansa Biopharma AB
Price target over the last 5 years
History of analyst recommendation changes
32a1e3ba4abe5c510facf56.Vu_zK69D3eheWLCUtgYIz_eF9kss-uI9N5hZUYgvcuw.Pr26EsBz7Jwua4TZ_ENShLCxpzIBoJVqDqtoOrhsLasXmbdO53Lt2xg83w~8cca7f1affa7b331308ac6c62c594313
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
29.48
SEK
Average target price
102.5
SEK
Spread / Average Target
+247.69%
High Price Target
174
SEK
Spread / Highest target
+490.23%
Low Price Target
48
SEK
Spread / Lowest Target
+62.82%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
C+
EPS Revisions
- Stock Market
- Equities
- HNSA Stock
- Consensus Hansa Biopharma AB
